What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
Richard G. Stock mainly focuses on Prostate cancer, Brachytherapy, Prostate, Surgery and Radiation therapy.
His Prostate cancer study integrates concerns from other disciplines, such as Implant and Ultrasound.
His work in Brachytherapy addresses issues such as Androgen deprivation therapy, which are connected to fields such as Prostatectomy.
His biological study spans a wide range of topics, including Nuclear medicine, Dosimetry and Urology.
His work in the fields of Stage overlaps with other areas such as Clinical Practice and Residency training.
The study incorporates disciplines such as Cancer, Medical physics and Oncology in addition to Radiation therapy.
His most cited work include:
- A dose-response study for I-125 prostate implants (485 citations)
- The american brachytherapy society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis (351 citations)
- Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. (350 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Prostate cancer, Brachytherapy, Internal medicine, Urology and Oncology.
The Prostate cancer study combines topics in areas such as Prostate and Radiation therapy.
All of his Brachytherapy and Prostate brachytherapy and External beam radiotherapy investigations are sub-components of the entire Brachytherapy study.
He combines subjects such as Gastroenterology, Single-nucleotide polymorphism, Genome-wide association study and Gynecology with his study of Internal medicine.
His work deals with themes such as PSA Failure, Urinary system, Stage, Hormone therapy and International Prostate Symptom Score, which intersect with Urology.
His Oncology research incorporates themes from Low-Dose Rate Brachytherapy, Breast cancer, Management of prostate cancer and Cohort.
He most often published in these fields:
- Prostate cancer (63.99%)
- Brachytherapy (45.08%)
- Internal medicine (41.45%)
What were the highlights of his more recent work (between 2015-2021)?
- Prostate cancer (63.99%)
- Internal medicine (41.45%)
- Brachytherapy (45.08%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Prostate cancer, Internal medicine, Brachytherapy, Oncology and Urology.
The various areas that Richard G. Stock examines in his Prostate cancer study include Hormone therapy, Radiology and External beam irradiation.
He interconnects Prostatectomy, Prostate, Androgen deprivation therapy and Proportional hazards model in the investigation of issues within Brachytherapy.
His study looks at the intersection of Prostate and topics like Dosimetry with Rectum.
His work is dedicated to discovering how Oncology, Biochemical recurrence are connected with Salvage therapy and other disciplines.
His Urology research includes elements of Prostate brachytherapy, External beam radiation, Quality of life, Stage and International Prostate Symptom Score.
Between 2015 and 2021, his most popular works were:
- Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. (135 citations)
- American Brachytherapy Society Task Group Report: Combination of brachytherapy and external beam radiation for high-risk prostate cancer. (48 citations)
- Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer. (47 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Prostate cancer
Prostate cancer, Brachytherapy, Internal medicine, Urology and Oncology are his primary areas of study.
His Prostate cancer study frequently draws connections to adjacent fields such as Hazard ratio.
His research integrates issues of Prostate-specific antigen, Prostate, Androgen deprivation therapy and Medical physics in his study of Brachytherapy.
The Radiation therapy, Cohort study and Immune checkpoint research he does as part of his general Internal medicine study is frequently linked to other disciplines of science, such as Context, therefore creating a link between diverse domains of science.
His Urology study combines topics from a wide range of disciplines, such as Low-Dose Rate Brachytherapy, Quality of life, Proportional hazards model, Hormone therapy and International Prostate Symptom Score.
His study in Oncology is interdisciplinary in nature, drawing from both Cancer, Surgery, Toxicity and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
